However, a recent study from Sunnybrook Research Institute offers some hope. Researchers found that a type of diabetes ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

2024 saw a new drug enter the dementia landscape, as the U.S. Food and Drug Administration ... more options and greater ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...

Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...

Experts believe role of the medication in reducing inflammation in the body – common to many conditions including dementia – ...

First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step ... 2024 — Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new ...